TRIDENT: A Phase 2 Study of Relacorilant Plus Nab-paclitaxel and Gemcitabine in Chemotherapy-naïve Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Presented: American Society of Clinical Oncology Annual Meeting, 30 May 2026, Chicago, IL
Presenter: Erkut H. Borazanci, MD, MS
Scientific journal publications or scientific congress presentations may include information regarding investigational products or uses.